Related Experiment Video
Updated: Jun 21, 2026

Optimizing the Growth of Endothiapepsin Crystals for Serial Crystallography Experiments
Published on: February 4, 2021
Crystallization challenges in drug development: scale-up from laboratory to pilot plant and beyond
S Desikan1, S R Anderson, P A Meenan
1DuPont Pharmaceutical, Solid-State Chemistry Laboratory, Chemical Process Research & Development, PRF Building S1, Deepwater, NJ 08023, USA. sridhar.desikan@dupontpharma.com
Abstract:
Crystallization is one of the most critical unit operations in the pharmaceutical industry. Pharmaceutical companies invest solid form of the drug substance. Rapid development of a candidate depends on the ability to produce desired drug substance with consistent properties as early as possible. This paper discusses the issues related to crystallization process laboratories at various stages in the drug development cycle. Critical issues at each stage of development, recent advances, and crystallization opportunities and their potential are outlined.
Related Concept Videos
Crystal Growth: Principles of Crystallization
Initiating crystallization involves manipulating the concentration of the solute and the temperature of the solution. Since crystal growth occurs when the ratio of concentration and solubility of the solute in the solvent – the...
Scale-Up Processes
Recrystallization: Solid–Solution Equilibria
Upstream Processing
Preclinical Development: Overview
Downstream Processing

